Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

CHPA statement on pediatrics study reporting medication errors in children The Consumer Healthcare Products Association (CHPA) issued the following statement in response to a study published today in Pediatrics. The study found that from 2002 to 2012 cough and cold medication errors decreased significantly in children under 6 years old, but the number of other medication errors rose to an average of 63,358 per year.
Production & Manufacturing > OTC > News
Therapix Biosciences signs non-binding agreement to acquire Dekel Pharmaceuticals Therapix Bio announces that it recently entered into a Term Sheet for the acquisition of Dekel Pharmaceuticals, a privately-held company engaged in the research and development of drug therapies based on synthetic cannabinoid substances.
Production & Manufacturing > OTC > News Cerus submits compassionate use IDE supplement for INTERCEPT Blood System treatment of ebola convalescent plasma Cerus announced submission of a clinical protocol to the U.S. Food and Drug Administration (FDA) to make the INTERCEPT Blood System for plasma available under a Compassionate Use Investigational Device Exemption (IDE) for treatment of convalescent plasma collected from Ebola disease survivors for passive immune therapy.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
Actavis seeks FDA approval to market Methylphenidate Hydrochloride 5mg/mL
By PBR Staff Writer
Irish pharmaceutical firm Actavis has submitted an abbreviated new drug application (ANDA) to the US Food and Drug Administration (FDA) seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5mg/mL.
Production & Manufacturing > OTC > News
Noven files patent infringement lawsuit against Actavis
Noven Pharmaceuticals has announced that it has filed a lawsuit in the U.S. District Court of New Jersey against Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Andrx Corp., and Actavis, Inc. for infringement of certain Noven patents.
Production & Manufacturing > OTC > News
Axxess Pharma launches new TapouT Turbo Blend protein powder
By PBR Staff Writer
Axxess Pharma through its subsidiary AllStar Health Brands has launched a new TapouT Turbo Blend Protein Powder.
Production & Manufacturing > OTC > News
Encore Consumer Capital announces sale of Isopure to Glanbia
Encore Consumer Capital, a private equity firm that invests exclusively in leading consumer products companies, has completed the sale of The Isopure Company, to Glanbia, the Ireland-based global performance nutrition and ingredients company, for $153m.
Production & Manufacturing > OTC > News
Macular Health announces release of MacuStrip
Macular Health, a recognized leader in the ophthalmic nutraceutical industry, is poised to introduce a breakthrough product to the marketplace: fast-dissolving, easy to use oral strips.
Production & Manufacturing > OTC > News
MissionPoint Health Partners and Second Harvest Food Bank of middle tennessee create partnership
MissionPoint Health Partners, a subsidiary of Ascension Health, the nation’s largest non-profit healthcare system, has created a partnership with Second Harvest Food Bank of Middle Tennessee to study the impact of nutrition on the healthcare organization’s food-insecure patients with hypertension or congestive heart failure (CHF), officials announced.
Production & Manufacturing > OTC > News
PuraMed nears completion of hemp-based OTC medication to treat epilepsy symptoms
By PBR Staff Writer
PuraMed BioScience, a US-based researcher, developer and marketer of over-the-counter (OTC) products, is nearing completion of its new non-prescription, hemp-based, homeopathic medication development to treat epilepsy symptoms including seizures and seizure-related headaches.
Production & Manufacturing > OTC > News
FDA warns consumers about some OTC medicines over possible impair driving
By PBR Staff Writer
The US Food and Drug administration (FDA) has cautioned consumers that the use of some common over-the counter (OTC) medications can make them drowsy and affect their ability to drive and operate machinery safely.
Production & Manufacturing > OTC > News
OTC pain medications are more effective for acute pain than prescribed painkillers: National Safety Council
National Safety Council released a white paper, Evidence for the efficacy of pain medications, compiling research showing the combination of over-the-counter pain medications ibuprofen and acetaminophen are more effective at treating acute pain than opioid painkillers.
Production & Manufacturing > OTC > News
Mary's Medicinals secures license to 40:1 CBD:THC Cannabis Strain from Green Natural Solutions
Mary's Medicinals, an exclusive producer and distributor of transdermal cannabis patches, gels and compounds, has announced a licensing agreement with Green Natural Solutions of Glenwood Springs, CO for exclusive access to its proprietary 40:1 CBD:THC strain, known as Mary's Healing Heart.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250